Transthyretin Amyloid Cardiomyopathy
20 clinical trials · Condition
◉ Watch Transthyretin Amyloid Cardiomyopathy
| Record | Firm | Date |
|---|---|---|
| SGLT2 Inhibitors in Transthyretin Amyloid Cardiomyopathy (NCT05233163) | Columbia University | 2022-03-14 |
| carDIo-ttranSSfOrm nucLEar Imaging Study (NCT05259072) | Oregon Health and Science University | 2022-01-19 |
| Artificial Intelligence to Assist the Echocardiographic Identification of Transthyretin Cardiac Amyloidosis (NCT06328075) | Algalarrondo Vincent | 2022-01-01 |
| A Study to Assess the Safety and Efficacy Of Tafamidis In Chinese Participants With Transthyretin Amyloid Cardiomyopathy (ATTR-CM) (NCT04814186) | Pfizer | 2021-07-22 |
| Global Prevalence of ATTR-CM in Participants With HFpEF (NCT04424914) | Pfizer | 2020-12-30 |
Track Transthyretin Amyloid Cardiomyopathy automatically
Every clearance here is in the API, with alerts when new ones post.